Skip to content
Subscriber Only
Technology
Prognosis

Flood of July Vaccine Data Starts on Pfizer Positive Note

  • Pfizer, BioNTech Covid-19 vaccine shows promise in early study
  • Results from Novavax and AstraZeneca also expected this month
A worker removes Covid-19 samples ran through a machine for analysis at a lab.
A worker removes Covid-19 samples ran through a machine for analysis at a lab.Photographer: Cole Burston/Bloomberg
Updated on

Exhausted health-care investors who might feel like they haven’t had a day off since March aren’t going to catch a break this summer, as a barrage of new data on Covid-19 vaccines and treatments are expected in the third quarter.

With more than 10 million confirmed cases around the globe and over half a million deaths from Covid-19, drug and vaccine makers are under increasing pressure to deliver.